Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3693-3700

  Qin, Shulin ^a   Alcorn, John F ^b   Craigo, Jodi K ^c,d   Tjoeng, Charis ^a   Tarwater, Patrick M ^e   Kolls, Jay K ^b,f,g   Reinhart, Todd A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e Paul L Foster School of Medicine   (United States)

^f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CELL TRANSFER; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SURFACE PLASMON RESONANCE; TH1 CELL;

ANIMALS; BINDING SITES; CATECHIN; CELL MIGRATION INHIBITION; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; CHEMOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MICE, TRANSGENIC;

EID: 79953196857     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002876     Document Type: Article

References (45)

1. Allen, S. J., S. E. Crown, and T. M. Handel. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25: 787-820.
2. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
3. Campanella, G. S., A. M. Tager, J. K. El Khoury, S. Y. Thomas, T. A. Abrazinski, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 105: 4814-4819.
4. Wark, P. A., F. Bucchieri, S. L. Johnston, P. G. Gibson, L. Hamilton, J. Mimica, G. Zummo, S. T. Holgate, J. Attia, A. Thakkinstian, and D. E. Davies. 2007. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 120: 586-593.
5. Larrubia, J. R., S. Benito-Martínez, M. Calvino, E. Sanz-de-Villalobos, and T. Parra-Cid. 2008. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J. Gastroenterol. 14: 7149-7159.
6. Shah, D., R. Kiran, A. Wanchu, and A. Bhatnagar. 2010. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol. Lett. 129: 7-12.
7. Jimenez-Alvarez, L., J. Zuniga, M. Gaxiola, M. Checa, C. Becerril, F. Mendoza, A. Pardo, and M. Selman. 2010. Inflammatory response and dynamics of lung T cell subsets in Th1, Th2 biased and Th2 deficient mice during the development of hypersensitivity pneumonitis. Exp. Mol. Pathol. 88: 407-415.
8. Hansen, G., G. Berry, R. H. DeKruyff, and D. T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103: 175-183.
9. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101: 746-754.
10. Kohlmeier, J. E., T. Cookenham, S. C. Miller, A. D. Roberts, J. P. Christensen, A. R. Thomsen, and D. L. Woodland. 2009. CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection. J. Immunol. 183: 4378-4384.
11. Trevisanato, S. I., and Y. I. Kim. 2000. Tea and health. Nutr. Rev. 58: 1-10.
12. Cabrera, C., R. Artacho, and R. Giménez. 2006. Beneficial effects of green tea - a review. J. Am. Coll. Nutr. 25: 79-99.
13. Rah, D. K., D. W. Han, H. S. Baek, S. H. Hyon, and J. C. Park. 2005. Prevention of reactive oxygen species-induced oxidative stress in human microvascular endothelial cells by green tea polyphenol. Toxicol. Lett. 155: 269-275.
14. Coimbra, S., E. Castro, P. Rocha-Pereira, I. Rebelo, S. Rocha, and A. Santos- Silva. 2006. The effect of green tea in oxidative stress. Clin. Nutr. 25: 790-796.
15. Abboud, P. A., P. W. Hake, T. J. Burroughs, K. Odoms, M. O'Connor, P. Mangeshkar, H. R. Wong, and B. Zingarelli. 2008. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur. J. Pharmacol. 579: 411-417.
16. Higdon, J. V., and B. Frei. 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 43: 89-143.
17. Ahmed, S., H. Marotte, K. Kwan, J. H. Ruth, P. L. Campbell, B. J. Rabquer, A. Pakozdi, and A. E. Koch. 2008. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl. Acad. Sci. USA 105: 14692-14697.
18. Shin, H. Y., S. H. Kim, H. J. Jeong, S. Y. Kim, T. Y. Shin, J. Y. Um, S. H. Hong, and H. M. Kim. 2007. Epigallocatechin-3-gallate inhibits secretion of TNFalpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int. Arch. Allergy Immunol. 142: 335-344.
19. Ahmed, S., A. Pakozdi, and A. E. Koch. 2006. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 54: 2393-2401.
20. Wheeler, D. S., J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra, and H. R. Wong. 2004. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J. Nutr. 134: 1039-1044.
21. Lin, S. K., H. H. Chang, Y. J. Chen, C. C. Wang, D. L. Galson, C. Y. Hong, and S. H. Kok. 2008. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/ Raf-1 interaction: a potential therapeutic benefit for arthritis. Arthritis Rheum. 58: 3145-3156.
22. Porath, D., C. Riegger, J. Drewe, and J. Schwager. 2005. Epigallocatechin-3- gallate impairs chemokine production in human colon epithelial cell lines. J. Pharmacol. Exp. Ther. 315: 1172-1180.
23. Ahn, H. Y., Y. Xu, and S. T. Davidge. 2008. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci. 82: 964-968.
24. Sriram, N., S. Kalayarasan, and G. Sudhandiran. 2009. Epigallocatechin-3- gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm. Pharmacol. Ther. 22: 221-236.
25. Donà, M., I. Dell'Aica, F. Calabrese, R. Benelli, M. Morini, A. Albini, and S. Garbisa. 2003. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 170: 4335-4341. (Pubitemid 36428203)
26. Takano, K., K. Nakaima, M. Nitta, F. Shibata, and H. Nakagawa. 2004. Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J. Agric. Food Chem. 52: 4571-4576.
27. Zhu, J., O. Wang, L. Ruan, X. Hou, Y. Cui, J. M. Wang, and Y. Le. 2009. The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int. Immunopharmacol. 9: 1126-1130.
28. Reinhart, T. A., B. A. Fallert, M. E. Pfeifer, S. Sanghavi, S. Capuano, III, P. Rajakumar, M. Murphey-Corb, R. Day, C. L. Fuller, and T. M. Schaefer. 2002. Increased expression of the inflammatory chemokine CXC chemokine ligand 9/ monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Blood 99: 3119-3128.
29. Qin, S., Y. Sui, A. C. Soloff, B. A. Junecko, D. E. Kirschner, M. A. Murphey- Corb, S. C. Watkins, P. M. Tarwater, J. E. Pease, S. M. Barratt-Boyes, and T. A. Reinhart. 2008. Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection. J. Immunol. 180: 5530-5536.
30. Mikhak, Z., A. Farsidjani, and A. D. Luster. 2009. Endotoxin augmented antigen-induced Th1 cell trafficking amplifies airway neutrophilic inflammation. J. Immunol. 182: 7946-7956.
31. Clement, Y. 2009. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 49: 83-87.
32. Wolfram, S. 2007. Effects of green tea and EGCG on cardiovascular and metabolic health. J. Am. Coll. Nutr. 26: 373S-388S.
33. Sarkar, F. H., Y. Li, Z. Wang, and D. Kong. 2009. Cellular signaling perturbation by natural products. Cell. Signal. 21: 1541-1547.
34. Khan, N., F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar. 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3- gallate. Cancer Res. 66: 2500-2505.
35. Salter, L., T. Clifford, N. Morley, D. Gould, S. Campbell, and A. Curnow. 2004. The use of comet assay data with a simple reaction mechanism to evaluate the relative effectiveness of free radical scavenging by quercetin, epigallocatechin gallate and N-acetylcysteine in UV-irradiated MRC5 lung fibroblasts. J. Photochem. Photobiol. B 75: 57-61.
36. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71: 173-183.
37. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Brière, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
38. Grumelli, S., D. B. Corry, L. Z. Song, L. Song, L. Green, J. Huh, J. Hacken, R. Espada, R. Bag, D. E. Lewis, and F. Kheradmand. 2004. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 1: e8.
39. Kawai, K., N. H. Tsuno, J. Kitayama, Y. Okaji, K. Yazawa, M. Asakage, N. Hori, T. Watanabe, K. Takahashi, and H. Nagawa. 2004. Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b. J. Allergy Clin. Immunol. 113: 1211-1217.
40. Noh, S. U., E. A. Cho, H. O. Kim, and Y. M. Park. 2008. Epigallocatechin-3- gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor. Int. Immunopharmacol. 8: 1172-1182.
41. Wang, Y., Y. Mei, D. Feng, and L. Xu. 2006. (-)-Epigallocatechin-3- gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Clin. Exp. Immunol. 145: 485-492.
42. Hosokawa, Y., I. Hosokawa, K. Ozaki, T. Nakanishi, H. Nakae, and T. Matsuo. 2010. Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts. J. Nutr. Biochem. 21: 659-664.
43. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968.
44. Gandhi, N. S., and R. L. Mancera. 2008. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72: 455-482.
45. Chen, X., J. A. Beutler, T. G. McCloud, A. Loehfelm, L. Yang, H. F. Dong, O. Y. Chertov, R. Salcedo, J. J. Oppenheim, and O. M. Howard. 2003. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Clin. Cancer Res. 9: 3115-3123.